Singapore, Jan. 27 -- Emagene Life, a leading functional medicine and longevity practice in Malaysia, has officially launched the Emagene Life Academy, marking a major milestone in the advancement of ... Read More
Singapore, Jan. 23 -- South Korea-based SK bioscience has announced that it is advancing the development of a Zaire ebolavirus vaccine under a new collaboration supported by Norway's Coalition for Epi... Read More
Singapore, Jan. 23 -- Japan-based pharmaceutical firm Daiichi Sankyo has further established its presence in Canada with the official opening of its permanent headquarters in Toronto, including additi... Read More
Singapore, Jan. 23 -- Sisram Medical, a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, has announced that its wholly-owned subsidiary, Sisra... Read More
Singapore, Jan. 21 -- Duke-NUS Medical School in Singapore has noted theannouncement by Boehringer Ingelheimof a Phase IIa clinical study evaluating BI 765423, a first-in-class IL-11 inhibitor for idi... Read More
Singapore, Jan. 21 -- US-based AbelZeta Pharma, Inc., a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic pr... Read More
Singapore, Jan. 21 -- US-based Pacira BioSciences, Inc. has entered into an agreement with South Korea's LG Chem designed to expand access to opioid-sparing postsurgical pain control for patients in s... Read More
Singapore, Jan. 21 -- GSK plc and Shionogi & Co. have reached an agreement together with Pfizer Inc. for the 11.7% economic interest in UK-based ViiV Healthcare Limited, currently held by Pfizer to be... Read More
Singapore, Jan. 19 -- Dentalkart, India's largest online marketplace for dental products, has announced a strategic partnership with NSK Japan, a global leader in dental rotary instruments and precisi... Read More
Singapore, Jan. 19 -- China-based startup Zonsen PepLib Biotech Inc. has entered into a worldwide license agreement with Novartis for an undisclosed peptide-based asset in the field of radioligand the... Read More